Placebo Alendronate

DRUG4 trials

Sponsors

Columbia University, Massachusetts General Hospital, University of Pittsburgh

Conditions

Bone ResorptionCardiac TransplantationHeart TransplantationHypogonadismLiver TransplantationOsteopeniaOsteoporosisOsteoporosis, Post-menopausal

Phase 2

Zoledronic Acid Versus Alendronate for Prevention of Bone Loss After Organ Transplantation

CompletedNCT00297830

Columbia UniversityBone Resorption, Heart Transplantation, Liver Transplantation

Start: 2005-11-30End: 2014-01-31Updated: 2018-08-16

Testosterone and Alendronate in Hypogonadal Men

TerminatedNCT01460654

Massachusetts General HospitalHypogonadism, Osteopenia, Osteoporosis

Start: 2011-10-31End: 2014-12-31Updated: 2023-10-12

Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes

WithdrawnNCT06973109

University of PittsburghOsteoporosis, Post-menopausal

Start: 2026-06-20End: 2027-06-01Updated: 2026-06-04

Phase 3

Osteoporosis Prevention After Heart Transplant

CompletedNCT00000412

Columbia UniversityCardiac Transplantation, Osteoporosis

Start: 1997-09-30End: 2002-04-30Updated: 2015-07-07